427 related articles for article (PubMed ID: 36923933)
21. Curcumin nanoformulations: Beneficial nanomedicine against cancer.
Maleki Dizaj S; Alipour M; Dalir Abdolahinia E; Ahmadian E; Eftekhari A; Forouhandeh H; Rahbar Saadat Y; Sharifi S; Zununi Vahed S
Phytother Res; 2022 Mar; 36(3):1156-1181. PubMed ID: 35129230
[TBL] [Abstract][Full Text] [Related]
22. Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment.
Gu X; Ding J; Zhang Z; Li Q; Zhuang X; Chen X
Curr Pharm Des; 2015; 21(36):5187-97. PubMed ID: 26412359
[TBL] [Abstract][Full Text] [Related]
23. Technological Interventions Enhancing Curcumin Bioavailability in Wound-Healing Therapeutics.
Singh H; Dhanka M; Yadav I; Gautam S; Bashir SM; Mishra NC; Arora T; Hassan S
Tissue Eng Part B Rev; 2024 Apr; 30(2):230-253. PubMed ID: 37897069
[TBL] [Abstract][Full Text] [Related]
24. The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma.
Dhule SS; Penfornis P; He J; Harris MR; Terry T; John V; Pochampally R
Mol Pharm; 2014 Feb; 11(2):417-27. PubMed ID: 24380633
[TBL] [Abstract][Full Text] [Related]
25. Solubility enhancement and delivery systems of curcumin a herbal medicine: a review.
Hani U; Shivakumar HG
Curr Drug Deliv; 2014; 11(6):792-804. PubMed ID: 25176028
[TBL] [Abstract][Full Text] [Related]
26. Nano-micelles based on hydroxyethyl starch-curcumin conjugates for improved stability, antioxidant and anticancer activity of curcumin.
Chen S; Wu J; Tang Q; Xu C; Huang Y; Huang D; Luo F; Wu Y; Yan F; Weng Z; Wang S
Carbohydr Polym; 2020 Jan; 228():115398. PubMed ID: 31635734
[TBL] [Abstract][Full Text] [Related]
27. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
Liang W; Dong Y; Shao R; Zhang S; Wu X; Huang X; Sun B; Zeng B; Zhao J
J Drug Target; 2022 Jun; 30(5):463-475. PubMed ID: 34962448
[TBL] [Abstract][Full Text] [Related]
28. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature.
PosthumaDeBoer J; Witlox MA; Kaspers GJ; van Royen BJ
Clin Exp Metastasis; 2011 Jun; 28(5):493-503. PubMed ID: 21461590
[TBL] [Abstract][Full Text] [Related]
29. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
30. Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: A review of new trends and future perspectives.
Hussain Z; Thu HE; Amjad MW; Hussain F; Ahmed TA; Khan S
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():1316-1326. PubMed ID: 28532009
[TBL] [Abstract][Full Text] [Related]
31. Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.
Hafez Ghoran S; Calcaterra A; Abbasi M; Taktaz F; Nieselt K; Babaei E
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014474
[TBL] [Abstract][Full Text] [Related]
32. New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma.
Lu KH; Lu EW; Lin CW; Yang JS; Yang SF
Pharmacol Ther; 2020 Oct; 214():107611. PubMed ID: 32565177
[TBL] [Abstract][Full Text] [Related]
33. Curcumin analogs: Their roles in pancreatic cancer growth and metastasis.
Nagaraju GP; Benton L; Bethi SR; Shoji M; El-Rayes BF
Int J Cancer; 2019 Jul; 145(1):10-19. PubMed ID: 30226272
[TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanism of Curcumin and Its Analogs as Multifunctional Compounds against Pancreatic Cancer.
Huang Q; Zhang Y; Zheng Y; Yang H; Yang Y; Mo Y; Li L; Zhang H
Nutr Cancer; 2022; 74(9):3096-3108. PubMed ID: 35583289
[TBL] [Abstract][Full Text] [Related]
35. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
[TBL] [Abstract][Full Text] [Related]
36. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
37. The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.
Tagde P; Tagde P; Islam F; Tagde S; Shah M; Hussain ZD; Rahman MH; Najda A; Alanazi IS; Germoush MO; Mohamed HRH; Algandaby MM; Nasrullah MZ; Kot N; Abdel-Daim MM
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885693
[TBL] [Abstract][Full Text] [Related]
38. Anti-microbial activity of curcumin nanoformulations: New trends and future perspectives.
Sharifi S; Fathi N; Memar MY; Hosseiniyan Khatibi SM; Khalilov R; Negahdari R; Zununi Vahed S; Maleki Dizaj S
Phytother Res; 2020 Aug; 34(8):1926-1946. PubMed ID: 32166813
[TBL] [Abstract][Full Text] [Related]
39. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.
Dhule SS; Penfornis P; Frazier T; Walker R; Feldman J; Tan G; He J; Alb A; John V; Pochampally R
Nanomedicine; 2012 May; 8(4):440-51. PubMed ID: 21839055
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma.
Salehi M; Movahedpour A; Tayarani A; Shabaninejad Z; Pourhanifeh MH; Mortezapour E; Nickdasti A; Mottaghi R; Davoodabadi A; Khan H; Savardashtaki A; Mirzaei H
Phytother Res; 2020 Oct; 34(10):2557-2576. PubMed ID: 32307773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
